JCI table of contents: January 19, 2006

ity of these Tregs, preventing them from suppressing the ongoing immune response, and thus ensuring clearance of the infection. Once the fungus is cleared by the immune system, the source of the TLR2 ligand is no longer present, and the Tregs regain their suppressive capabilities. This explains how TLR2 can directly control Treg function and allows Tregs to behave differently before, during, and after infection. This control mechanism contributes to the balance between the mounting of an effective immune response and the development of autoimmunity.

TITLE: Toll-like receptor 2 controls expansion and function of regulatory T cells

Gosse J. Adema
Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Phone: 31-24-361-7600; Fax: 31-24-354-0339; E-mail: G.Adema@ncmls.ru.nl

View the PDF of this article at: https://www.the-jci.org/article.php?id=25439

Clues to rare immunodeficiency disorder identified

Patients who suffer from the rare, often fatal X-linked proliferative disease (XLP) have a severe deficiency of special immune cells called CD27+ (or memory) B cells, and are highly susceptible to infection with Epstein Barr Virus (EBV). XLP patients are characterized by hypogammaglobulinemia, infectious mononucleosis, and/or lymphoma. It was previously shown that XLP CD27+ cells also express a marker of nave B cells (IgM+) and it was unclear whether these IgM+CD27+ B cells in XLP patients could produce immunoglobulin (Ig) or function as normal memory B cells. New research by Stuart Tangye and colleagues at the Centenary Institute of Cancer Medicine and Cell Biology in Sydney, Australia demonstrates that these cells are indeed functional memory B cells. Their study, appearing online on January 19 in advance of print publication in the February 2006 issue o

Contact: Brooke Grindlinger
Journal of Clinical Investigation

Page: 1 2 3 4 5 6

Related medicine news :

1. International symposium on fruit, vegetables headed for Houston
2. Stevens Roundtable: Health, Technology & Society, July 11
3. FDA approves ZYFLO CR extended-release tablets for chronic treatment of asthma
4. Once-fatal metabolic disorders treatable, says Stanford/Packard researcher
5. Clinical review -- A psychological approach to the management of irritable bowel syndrome
6. JCI table of contents -- May 17, 2007
7. JCI table of contents: May 10, 2007
8. New treatments needed for irritable bowel syndrome
9. JCI table of contents: May 1, 2007
10. Americans still not eating enough fruits and vegetables, according to 2 recent studies
11. Slow-release morphine reduces level of intractable cough

Post Your Comments:

(Date:1/14/2019)... ... January 14, 2019 , ... Modere (the “Company”), ... with a presence worldwide, today announced that it built on 2017’s growth momentum, ... grew by double-digits in North America, by more than five times in Europe ...
(Date:1/14/2019)... ... January 14, 2019 , ... The ... availability of VARIZIG® (Varicella Zoster Immune Globulin [Human]) for post-exposure prophylaxis of ... the update, the CDC notes that VARIZIG is commercially available from a broad ...
(Date:1/14/2019)... ... 2019 , ... Dr. Kaveh Kanani D.D.S . is the head of Around the Corner ... general dentist has recently unveiled an inventive method of inserting dental implants. , ... is missing for an extended period of time, the jawbone that used to hold the ...
(Date:1/13/2019)... ... January 12, 2019 , ... On December 13th, The Pennsylvania ... hosted a continuing education (CEU) event entitled, Can You Hear Me Now? Creating ... a series of talks to help develop and cultivate the relationship between mentors ...
(Date:1/11/2019)... ... 11, 2019 , ... In Partnership with the Smiles for Everyone Foundation ... at its Burleson, TX office on February 9. , Dental services provided ... and extractions . For more information, please visit the Monarch Dental website ...
Breaking Medicine News(10 mins):
(Date:1/10/2019)... (PRWEB) , ... January 10, 2019 , ... ... wellness company providing nutrition and lifestyle solutions, will crown the U.S. winner of ... Period’s 15 finalists include: Andrea Carrara of Palm Beach, Florida; Barbara Lingle of ...
(Date:1/8/2019)... , ... January 08, 2019 , ... ... been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. ... System and demonstrated a commitment to exemplary care for men suffering from symptoms ...
(Date:1/8/2019)... ... January 08, 2019 , ... Date aired: August 13th, 2018 , Guest: ... excessive evaporation of the tear film, which is naturally 99 percent water, and it ... says water researcher Sharon Kleyne, host of the internationally syndicated radio program, The Sharon ...
Breaking Medicine Technology:
Cached News: